Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Gedeon

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral gliomaBryan D Choi, Chien-Tsun Kuan, Mingqing Cai, et al.
Molecular Cell|December 20, 2024
RNA sensing induced by chromosome missegregation augments anti-tumor immunityNobunari Sasaki, Mizuki Homme, Takahiko Murayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2018
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted HostsCarter M Suryadevara, Rupen Desai, S Harrison Farber, et al.
Oncoimmunology|June 7, 2018
Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastomaCarter M Suryadevara, Rupen Desai, Melissa L Abel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2018
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant GliomaPatrick C Gedeon, Teilo H Schaller, Satish K Chitneni, et al.
Nature Communications|May 2, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancerZehua Li, Cong Fu, Kartik Sehgal, et al.
Cancer Research|November 3, 2017
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in GlioblastomaElizabeth A Reap, Carter M Suryadevara, Kristen A Batich, et al.
Cancer Immunology Research|June 12, 2025
Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor That Unleashes PD-1 Checkpoint and CAR T-Cell ImmunotherapiesMichael Wichroski, Si-Qi Liu, Lauren M Zasadil, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral gliomaBryan D Choi, Chien-Tsun Kuan, Mingqing Cai, et al.
Molecular Cell|December 20, 2024
RNA sensing induced by chromosome missegregation augments anti-tumor immunityNobunari Sasaki, Mizuki Homme, Takahiko Murayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2018
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted HostsCarter M Suryadevara, Rupen Desai, S Harrison Farber, et al.
Oncoimmunology|June 7, 2018
Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastomaCarter M Suryadevara, Rupen Desai, Melissa L Abel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2018
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant GliomaPatrick C Gedeon, Teilo H Schaller, Satish K Chitneni, et al.
Nature Communications|May 2, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancerZehua Li, Cong Fu, Kartik Sehgal, et al.
Cancer Research|November 3, 2017
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in GlioblastomaElizabeth A Reap, Carter M Suryadevara, Kristen A Batich, et al.
Cancer Immunology Research|June 12, 2025
Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor That Unleashes PD-1 Checkpoint and CAR T-Cell ImmunotherapiesMichael Wichroski, Si-Qi Liu, Lauren M Zasadil, et al.
Pageof 3